Mesa Laboratories (MLAB) Proxy Filing summary

Executive summary

• Annual meeting scheduled for August 30, 2024, with shareholders voting on director elections, auditor ratification, and executive compensation.

• Company focused on sustainable business improvement, governance enhancements, and value creation.

• Fiscal year 2024 saw challenging macroeconomic conditions, but progress was made in operational efficiency, acquisitions, and ESG disclosures.

Voting matters and shareholder proposals

• Shareholders will vote on electing seven directors for one-year terms, ratifying RSM US LLP as auditor, and an advisory say-on-pay vote.

• Board unanimously recommends voting for all proposals.

• Shareholder engagement included outreach to holders of 75% of shares, with feedback incorporated into governance and compensation practices.

Board of directors and corporate governance

• Board consists of seven members, six of whom are independent; 43% are diverse by gender or ethnicity.

• Board refreshment continued with the addition of a new director in 2024.

• Annual board and committee self-assessments are conducted.

• Lead Independent Director role maintained; Chairperson and CEO roles are separated.

• All directors attended 100% of meetings in fiscal 2024.